Consenting for treatment in advance to reduce leaving the hospital against medical advice among patients with addiction — Experts debate pros and cons

January 22, 2021 — Patients with substance use disorders (SUDs) being treated for serious medical conditions are more likely to leave the hospital against medical advice (AMA) than those without addiction. A special type of contract with healthcare providers might enable patients to consent in advance to life-saving medical care — even if they later…

Details

Lack of sleep, stress can lead to symptoms resembling concussion

COLUMBUS, Ohio — A new study suggests that a lot of people might be going through life with symptoms that resemble concussion — a finding supporting researchers’ argument that athletes recovering from a brain injury should be assessed and treated on a highly individualized basis. In the national study, between 11% and 27% of healthy…

Details

Dramatic changes to radiotherapy treatments due to COVID-19

Dramatic changes were seen in the delivery of radiotherapy treatments for cancer during the first wave of the coronavirus pandemic in England. Much shorter radiotherapy courses were delivered, treatments were delayed where it was safe to do so and some increases were seen in order to compensate for reduced surgical capacity. Experts believe the changes…

Details

Massey researchers review geographic factors that affect HPV vaccination rates

Human papillomavirus (HPV) is the most common sexually transmitted infection, with an estimated 79 million Americans currently infected with the virus, according to the Centers for Disease Control and Prevention. If a high-risk HPV infection does not go away, it can lead to the development of a variety of cancers, including 91% of all cervical…

Details

NIH-funded study examines mono, chronic fatigue syndrome in college students

Many college students fully recover from infectious mononucleosis (which is almost always caused by Epstein-Barr virus) within 1-6 weeks, but some go on to develop chronic fatigue syndrome, also called myalgic encephalomyelitis (ME/CFS). A longitudinal study from DePaul University and Northwestern University followed 4,501 college students to examine risk factors that may trigger longer illness.…

Details

Corning Life Sciences to share suite of 3D cell culture technologies at SLAS2021

CORNING, N.Y. — Corning Incorporated (NYSE: GLW) will highlight its latest technologies that support the advancement of 3D cell culture, automation, and drug discovery at this year’s virtual Society for Laboratory Automation and Screening (SLAS) conference on Jan. 25 through 27. Now more than ever, tools used to facilitate scale-up, reproducibility, and consistency of 3D…

Details

NSAIDs might exacerbate or suppress COVID-19 depending on timing, mouse study suggests

Washington, DC — January 22, 2021 — New research shows that non-steroidal anti-inflammatory drugs (NSAIDs) reduced both antibody and inflammatory responses to SARS-CoV-2 infection in mice. The study appears this week in the Journal of Virology, a publication of the American Society for Microbiology. The research is important because «NSAIDs are arguably the most commonly…

Details

Join best-selling author James Nestor on ‘breath’ and sinus health

WHAT: Chronic sinusitis is a major health problem, impacting 30 million Americans. For more than 65 years, the American Rhinologic Society (ARS) has promoted excellence in the care of patients with nose, sinus, and skullbase disorders through research, education, and advocacy. Dedicated to fostering rhinologic research and breakthrough science that advances patient care and improves…

Details

Rhesus macaques develop promising immune response to SARS-CoV-2

In a promising result for the success of vaccines against COVID-19, rhesus macaque monkeys infected with the human coronavirus SARS-CoV-2 developed protective immune responses that might be reproduced with a vaccine. The work was carried out at the California National Primate Research Center at the University of California, Davis and is published Jan. 22 in…

Details